Emerging Infections

Institute for Emerging Infections

What are we doing?
We are working to understand the underlying processes that drive the emergence and spread of human infectious diseases. Our goal is to develop new medical therapies to cure chronic viral infections.

Why is it important?
New infections still present a threat to humanity. Novel pathogens often infect humans, but it is not yet well understood why only some pathogens acquire the ability to spread efficiently to other humans. With greater insight into how infections spread across populations, we can improve our progress in developing new and effective treatments to cure infectious disease.

How are we different?
We use both experimental and modelling work to learn about how viruses evolve and spread. By combining mathematical modelling with clinical practice to examine pathogen behaviour, we are better able to anticipate and prepare for the challenges posed by novel infections. As ever more anti-viral drugs are being approved and new, cheap ways of reading host and virus gene sequences let us “watch” as events unfold inside infected people, it becomes possible to permanently clear infection and so cure patients. We will use this better understanding of viral clearance to develop therapies that are tailored to individual patients.

Success in the 2012 Oxford Martin School funding round has enabled the Institute for Emerging Infections to launch a new research stream aiming to cure Hepatitis C (HCV) and sustainably suppress HIV replication. Find out more

Contact Us

Categories: Health & Medicine


Angela McLean

Professor Angela McLean

Professor of Mathematical Biology
Rodney Phillips

Professor Rodney Phillips

Professor of Clinical Medicine

Principal Investigators

Ellie Barnes

Dr Ellie Barnes

MRC Senior Clinical Fellow and Honorary Consultant in Hepatology
John Frater

Dr John Frater

Clinical Research Fellow
Paul Klenerman

Professor Paul Klenerman

Professor of Immunology
Oliver Pybus

Professor Oliver Pybus

Professor of Evolution & Infectious Disease
Daniel Wilson

Dr Daniel Wilson

Wellcome Trust/Royal Society Sir Henry Dale Fellow


Helen Fryer

Dr Helen Fryer

Postdoctoral Researcher